Cargando…
Quantification of trivalent non-replicating rotavirus vaccine antigens in the presence of aluminum adjuvant
Parenterally administered rotavirus vaccines may overcome the low efficacy observed in resource-poor regions that use live oral formulations. We have reported work on a trivalent nonreplicating rotavirus vaccine (NRRV) for parenteral administration consisting of the recombinant tetanus toxoid P2 CD4...
Autores principales: | McAdams, David, Lakatos, Kyle, Estrada, Marcus, Chen, Dexiang, Plikaytis, Brian, Sitrin, Robert, White, Jessica A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208242/ https://www.ncbi.nlm.nih.gov/pubmed/33857473 http://dx.doi.org/10.1016/j.jim.2021.113056 |
Ejemplares similares
-
Formulation and preclinical studies with a trivalent rotavirus P2-VP8 subunit vaccine
por: Lakatos, Kyle, et al.
Publicado: (2020) -
Concordance of in vitro and in vivo measures of non-replicating rotavirus vaccine potency
por: McAdams, David, et al.
Publicado: (2022) -
Effect of Aluminum Adjuvant and Preservatives on Structural Integrity and Physicochemical Stability Profiles of Three Recombinant Subunit Rotavirus Vaccine Antigens
por: Agarwal, Sanjeev, et al.
Publicado: (2020) -
Recombinant Subunit Rotavirus Trivalent Vaccine Candidate: Physicochemical Comparisons and Stability Evaluations of Three Protein Antigens
por: Agarwal, Sanjeev, et al.
Publicado: (2019) -
Characterizing and Minimizing Aggregation and Particle Formation of Three Recombinant Fusion-Protein Bulk Antigens for Use in a Candidate Trivalent Rotavirus Vaccine
por: Agarwal, Sanjeev, et al.
Publicado: (2020)